** Shares of chemicals maker Chemours CC.N up 3.1% at $17.35 premarket
** Company posts smaller Q4 loss of $8 million compared to $18 million a year ago
** Co says it has fully addressed all four material weaknesses in internal control previously identified in the 2023 Form 10-K
** CC expects consolidated net sales to be flat to slightly down sequentially in Q1
** YTD shares down 0.41% as of last close
(Reporting by Katha Kalia)
((Katha.Kalia@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。